13.91

0.58% 0.08

Immix Biopharma Inc (IMMX)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Schlusskurs vom Vortag:

$13.83

Offen:

$13.68

24-Stunden-Volumen:

1.05M

Relative Volume:

0.56

Marktkapitalisierung:

$990.25M

Einnahmen:

Nettoeinkommen (Verlust:

$-34.98M

KGV:

-15.12

EPS:

-0.9199

Netto-Cashflow:

$-32.77M

1W Leistung:

-0.22%

1M Leistung:

+49.09%

6M Leistung:

+62.50%

1J Leistung:

+535.16%

1-Tages-Spanne:

$13.60

$14.09

1-Wochen-Bereich:

$13.42

$14.26

52-Wochen-Spanne:

$1.94

$15.10

Immix Biopharma Inc Stock (IMMX) Company Profile

Firmenname

Immix Biopharma Inc

Sektor

Healthcare (1074)

Branche

Biotechnology (600)

Telefon

(888) 958-1084

Adresse

11400 WEST OLYMPIC BLVD., LOS ANGELES

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-08-14

Neueste SEC-Einreichungen

IMMX's Discussions on Twitter

Compare IMMX vs VRTX, REGN, ARGX, MRNA, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
IMMX Immix Biopharma Inc	13.91	936.86M	0	-34.98M	-32.77M	-0.9199
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Immix Biopharma Inc Stock (IMMX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-03-25	Eingeleitet	Morgan Stanley	Overweight
2026-03-09	Eingeleitet	Citizens	Mkt Outperform
2026-02-09	Eingeleitet	Mizuho	Outperform

Immix Biopharma Inc Aktie (IMMX) Neueste Nachrichten

Aug 21, 2026

Tocqueville Asset Management L.P. Buys New Position in Immix Biopharma, Inc. $IMMX - MarketBeat

Aug 21, 2026

Blue Owl Capital Holdings LP Makes New $4.51 Million Investment in Immix Biopharma, Inc. $IMMX - MarketBeat

Aug 21, 2026

Aug 19, 2026

Immix Biopharma (IMMX) gains 5.6% stake holder led by Eventide Asset Management - Stock Titan

Aug 14, 2026

Citizens reiterates Immix Biopharma stock rating on pipeline progress By Investing.com - Investing.com Australia

Aug 14, 2026

Citizens reiterates Immix Biopharma stock rating on pipeline progress - Investing.com

Aug 14, 2026

Morgan Stanley Adjusts PT on Immix Biopharma to $19 From $20, Maintains Overweight Rating - Moomoo

Aug 14, 2026

Aug 13, 2026

Janus Henderson Group (IMMX) discloses 9.78M-share beneficial stake in Immix Biopharma - Stock Titan

Aug 13, 2026

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Immix Biopharma, Inc.IMMX - PR Newswire

Aug 13, 2026

Aug 12, 2026

Immix Biopharma Q3 EPS Estimate Lowered by HC Wainwright - MarketBeat

Aug 12, 2026

Aug 11, 2026

Immix Biopharma (NASDAQ:IMMX) Trading 7.1% HigherStill a Buy? - MarketBeat

Aug 11, 2026

HC Wainwright Estimates Immix Biopharma FY2027 Earnings - MarketBeat

Aug 11, 2026

Immix Biopharma publishes corporate presentation on NXC-201 BCMA CAR-T in relapsed/refractory AL amyloidosis - Bitget

Aug 11, 2026

Immix Biopharma, Inc. Stock 12‑Month Price Target Cut to $20.44, Implies 102% Upside - TradingView

Aug 11, 2026

Aug 10, 2026

IMMIX BIOPHARMA, INC. : H.C. WAINWRIGHT RAISES TARGET PRICE TO $25 FROM $20 - Bitget

Aug 10, 2026

H.C. Wainwright raises Immix Biopharma price target to $25 By Investing.com - Investing.com Australia

Aug 10, 2026

H.C. Wainwright raises Immix Biopharma price target to $25 - Investing.com India

Aug 10, 2026

Regulatory and Data Risks Loom Over Immix Biopharma’s Clinical Programs and Valuation - TipRanks

Aug 10, 2026

Aug 07, 2026

Immix Biopharma (NASDAQ:IMMX) Announces Quarterly Earnings Results - MarketBeat

Aug 07, 2026

Immix Biopharma (NASDAQ: IMMX) ends Q2 2026 with $232.1M in cash - Stock Titan

Aug 07, 2026

Immix Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 07, 2026

Immix Biopharma (NASDAQ:IMMX) Stock Price Down 6.7%Here's What Happened - MarketBeat

Aug 07, 2026